By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
DelMar Pharmaceuticals To Present At The 27th Annual ROTH Conference On March 10, 2015 3/3/2015 10:36:30 AM
DelMar Pharmaceuticals Receives Notice Of Allowance Of Fourth U.S. Patent Covering Methods Of Use And Compositions For VAL-083 3/2/2015 9:26:07 AM
EXCLUSIVE: DelMar Pharmaceuticals CEO Outlines 2015 Plans, Looks to Clinical Cancer Trials 2/27/2015 2:42:17 PM
EXCLUSIVE: Science "Finally Catching Up" With GBM Tumors, Says DelMar Pharmaceuticals CEO 2/26/2015 12:55:08 PM
DelMar Pharmaceuticals To Present Clinical And Preclinical Abstracts For VAL-083 At The American Association for Cancer Research Annual Meeting In April 2015 2/24/2015 6:46:17 AM
DelMar Pharmaceuticals Announces December 31, 2014 Financial Results And Provides Corporate Update 2/12/2015 7:28:44 AM
DelMar Pharmaceuticals Appoints Lynda Cranston, BScN, MScN, ICD.D, To The Board Of Directors 2/11/2015 10:40:03 AM
DelMar Pharmaceuticals Completes Offer To Exchange Common Stock For Outstanding Warrants 2/10/2015 11:30:03 AM
DelMar Pharmaceuticals Receives Notice Of Allowance For Third US Patent For VAL-083 1/13/2015 7:32:48 AM
DelMar Pharmaceuticals Provides Update On VAL-083 Clinical Trial And Outlines Corporate Objectives For 2015 1/12/2015 8:27:57 AM